Navigation Links
Chiltern Wins Two Pharma Awards at the Prestigious Annual Pharmatimes Awards Ceremony
Date:2/17/2012

LONDON, Feb. 17, 2012 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Chiltern has won two awards at the PharmaTimes Annual Awards 2011 ceremony held February 16, 2012 at the Park Plaza Riverbank Hotel in London. The competition, established in 1999, celebrates the competence and ability of top clinical research professionals.

Glenn Kerkhof, Chiltern CEO, congratulates all of Chiltern's Award Winners and Finalists. "I couldn't be more proud of every Chiltern colleague nominated for an award and this recognition is a testament to their outstanding abilities. Their achievements support Chiltern's mission to deliver high quality services around the world, while demonstrating our commitment to clients' needs."

Linda Christmas, Sr. Executive VP, Global Resourcing Solutions, Chiltern, stated, "I am delighted that our finalists represent not only Chiltern's outstanding operational people but also our dedicated and professional recruitment team. This further demonstrates not only our ability to deliver world class operational services via our internal teams, but also to place exceptional talent direct with our clients and furthermore an outstanding recruitment and personnel placement service. I am absolutely delighted to be able to work with such a great team each and every day."

Chiltern Award WinnersClinical Recruiter of the Year Bronze Award: Marc Joseph, Resourcing Manager, Chiltern Resourcing Solutions

Clinical Research Associate of the Year Silver Award: Danielle Fairclough, client based Clinical Research Professional via Chiltern Resourcing Solutions

Company profileAbout Chiltern:Established in 1982, Chiltern is a leading global clinical CRO with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas, functional service provision and contract staffing solutions. Chiltern has conducted trials in more than 40 countries, employs nearly 1,300 people globally and offers services in Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Chiltern prides itself as a development partner that offers flexibility, responsiveness and quality delivery. Further information is available at: www.chiltern.com.

 For More Information Contact: 

 Natalie Chong

Susan OjanenMarketing Director

Marketing ExecutiveChiltern International Ltd.

Chiltern International Inc.171 Bath Road

1241 Volunteer Parkway, Suite 950Slough, Berkshire SL1 4AA

Bristol, TN 3762UNITED KINGDOM

USATel:  +44 (0) 1753 512 000

Tel:  +1 (423) 968 9533Email: natalie.chong@chiltern.com

Email: susan.ojanen@chiltern.com 

 


'/>"/>

SOURCE Chiltern
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Chiltern Expands North American Operations With a New Office in Illinois
2. Chiltern - Spectratox Drug Photoxicity Collaboration Celebrates 25 Years
3. Chiltern Wins Multiple Pharma Awards at the Prestigious Annual PharmaTimes Awards Ceremony
4. NABP Supports Legislation Aimed to Protect Patients from Counterfeit Drugs and Fake Online Pharmacies
5. SCOLR Pharma, Inc. Launches Cutting Edge Nutritional Products at Major Retailers in 2012
6. Access Pharmaceuticals MuGard Added to Nationally Ranked Childrens Hospital of Colorado Pharmacy Formulary
7. PDL BioPharma to Announce Fourth Quarter and Full Year 2011 Financial Results on February 23, 2012
8. Questcor Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors
9. IntegriChain Delivers Pharmacy Level Inventory Metrics
10. ViroPharma to Release 2011 Fourth Quarter and Full Year Financial Results on February 28, 2012
11. American Academy of Dermatology and LEO Pharma Launch Educational Website to Raise Awareness About Sun Damage and Skin Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Feb. 9, 2016 On ... Administration (FDA) met with its Arthritis Advisory ... biosimilar of Johnson & Johnson,s Remicade and ... approved in the U.S. The Biologics Prescribers ... groups - Alliance for Patient Access, American ...
(Date:2/10/2016)... February 10, 2016 Demonstrates ... 1 receptor selectivity   1 ... which has entered clinical development as a new ... and schizophrenia.   --> 1 ... has entered clinical development as a new treatment ...
(Date:2/9/2016)... 9, 2016  Insulet Corporation (NASDAQ: PODD ) (Insulet ... technology with its OmniPod ® Insulin ... has been appointed to Insulet,s Board of Directors. With his ... of whom are independent. --> ... and finance experience and a deep knowledge of accounting, financial ...
Breaking Medicine Technology:
(Date:2/10/2016)... La Puente, California (PRWEB) , ... February 09, ... ... Dental Medicine students, faculty and staff helped give free oral screenings to 150 ... California Feb. 5, 2016. , The College of Dental Medicine joined Chinese American ...
(Date:2/9/2016)... Fort Lauderdale, Florida (PRWEB) , ... February 09, 2016 , ... ... known as the Taste of South Florida Event, an upscale fundraiser held in South ... to wow sponsors and guests alike. This year the event will be held in ...
(Date:2/9/2016)... ... February 09, 2016 , ... A new study ... rates and Medicare rates for a variety of medical services in Illinois as ... of the 2015 Fee Schedule Rates in Illinois, are professional medical services, ...
(Date:2/9/2016)... ... , ... On January 12, 2016 Paul McElwee, a CroppMetcalfe HVAC technician, visited ... not producing any heat. Shortly after entering the home, Paul was able to identify ... levels of carbon monoxide into the home, at 2,000 parts per million in the ...
(Date:2/9/2016)... , ... February 09, 2016 , ... ... The guide will ensure lab personnel have a basic understanding of the techniques ... measurement protocols. Enhanced understanding will help them reduce waste and rework to create ...
Breaking Medicine News(10 mins):